보포스트 그룹
평가액
$10.29B
보유 종목
31
상위 10 비중
77.1%
보유 종목
31종목| 종목 | 보유수량 | 평가액 ▼ | 신고가 | 현재가 | ±신고 | 52주 | 비중 |
|---|---|---|---|---|---|---|---|
| CHENIERE ENERGY INC | 20,726,340 | $1.108B | $53.45 | $308.75 | +477.6% | $188.83 – $330.32 | 10.8% |
| SYNCHRONY FINANCIAL | 29,295,030 | $982.3M | $33.53 | $72.25 | +115.5% | $63.78 – $88.47 | 9.5% |
| NEWS CORP | 26,588,731 | $975.5M | $36.69 | - | - | - | 9.5% |
| VIASAT INC | 13,658,137 | $897.6M | $65.72 | $67.72 | +3.0% | $30.35 – $89.81 | 8.7% |
| ALLERGAN PLC | 4,750,000 | $799.4M | $168.29 | - | - | - | 7.8% |
| QORVO INC | 11,000,000 | $775M | $70.45 | - | - | - | 7.5% |
| TIME WARNER INC | 8,100,000 | $766.1M | $94.58 | - | - | - | 7.4% |
| PIONEER NAT RES CO | 4,000,000 | $687.1M | $171.78 | - | - | - | 6.7% |
| ANTERO RESOURCES CORP | 26,587,791 | $527.8M | $19.85 | $38.74 | +95.2% | $31.38 – $45.15 | 5.1% |
| TWENTY FIRST CENTY FOX INC | 11,433,358 | $415.8M | $36.37 | - | - | - | 4.0% |
| CARDINAL HEALTH INC | 5,100,000 | $319.7M | $62.68 | $281.10 | +348.5% | $182.50 – $281.10 | 3.1% |
| COLONY NORTHSTAR INC | 49,687,370 | $279.2M | $5.62 | - | - | - | 2.7% |
| PBF ENERGY INC | 7,924,175 | $268.6M | $33.90 | $71.28 | +110.3% | $26.02 – $91.17 | 2.6% |
| ATARA BIOTHERAPEUTICS INC | 6,254,632 | $243.9M | $39.00 | - | - | - | 2.4% |
| MCKESSON CORP | 1,615,700 | $227.6M | $140.87 | $1,102.81 | +682.9% | $725.17 – $1,102.81 | 2.2% |
| THERAVANCE BIOPHARMA INC | 9,309,168 | $225.7M | $24.25 | - | - | - | 2.2% |
| VERITIV CORP | 3,824,385 | $149.9M | $39.20 | - | - | - | 1.5% |
| PG&E CORP | 3,149,972 | $138.4M | $43.93 | $13.25 | -69.8% | $11.95 – $19.11 | 1.3% |
| CENCORA INC | 1,317,216 | $113.6M | $86.21 | $359.03 | +316.5% | $252.74 – $374.75 | 1.1% |
| KERYX BIOPHARMACEUTICALS INC | 25,791,678 | $105.5M | $4.09 | - | - | - | 1.0% |
| AMC ENTMT HLDGS INC | 5,000,000 | $70.25M | $14.05 | - | - | - | 0.7% |
| NOVAGOLD RES INC | 13,467,145 | $58.31M | $4.33 | $5.63 | +30.0% | $5.18 – $14.20 | 0.6% |
| GTY TECHNOLOGY HOLDINGS INC | 4,400,000 | $45.54M | $10.35 | - | - | - | 0.4% |
| PARATEK PHARMACEUTICALS INC | 2,394,498 | $31.13M | $13.00 | - | - | - | 0.3% |
| SABAN CAP ACQUISITION CORP | 2,326,500 | $23.13M | $9.94 | - | - | - | 0.2% |
| SENTINEL ENERGY SVCS INC | 1,600,000 | $15.87M | $9.92 | - | - | - | 0.2% |
| CHIPMOS TECHNOLOGIES INC | 933,658 | $14.8M | $15.85 | - | - | - | 0.1% |
| TRILOGY METALS INC NEW | 10,600,758 | $13.41M | $1.26 | $1.94 | +53.4% | $1.94 – $6.89 | 0.1% |
| FORWARD PHARMA A/S | 2,848,003 | $6.18M | $2.17 | - | - | - | 0.1% |
| SABAN CAP ACQUISITION CORP | 1,163,250 | $1.512M | $1.30 | - | - | - | 0.0% |
| OREXIGEN THERAPEUTICS INC | 2,226,839 | $465K | $0.21 | - | - | - | 0.0% |
33개 신고 항목을 31개 CUSIP으로 합산했습니다. 위임 운용사별로 나뉜 항목은 합산합니다.
13F는 롱 포지션만(롱옵션 포함, 숏·현금 제외)이며 분기말 기준입니다.
그 외 신고 항목
2건| 종목 | 종류 | 수량·원금 | 평가액 |
|---|---|---|---|
| TESLA INC | 원금 표시(채권·노트) | 50,000,000 | $52.19M |
| THERAVANCE BIOPHARMA INC | 원금 표시(채권·노트) | 30,000,000 | $30.21M |
채권·노트(원금 표시)·선호주·예탁증권·값 없는 항목·옵션(콜·풋)은 참고로 싣되 평가액·종목수에는 세지 않습니다 — 주식수 기준·값 0 초과·옵션 제외·선호주 제외(Dataroma 방식). 옵션은 계약 수가 아니라 기초 주식수와 그 평가액으로 적습니다.